Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-09

Clinical Trial Update: Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Cycloset added to metformin versus placebo added to metformin in type 2 diabetes; the study was terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSET (BROMOCRIPTINE MESYLATE)

Snippet

Sponsor: VeroScience | Conditions: Type 2 Diabetes | Phase 3 | Status: TERMINATED | Results posted: 2016-05-09